HIV vaccine triggers broadly neutralizing antibodies in 44% of primates

A caller HIV vaccine developed by La Jolla Institute for Immunology (LJI), Scripps Research scientists and IAVI has the imaginable to support humans from processing HIV corruption and AIDS. This HIV vaccine is the archetypal to make a precocious fig of "broadly neutralizing" virus-fighting antibodies successful primates. The probe is published successful the diary Nature.